NCT02345343View on ClinicalTrials.gov

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 4, 2015

Primary Completion Date

October 7, 2015

Study Completion Date

October 7, 2015

Conditions
Deep Vein ThrombosisPulmonary Embolism
Interventions
DRUG

Apixaban

Trial Locations (1)

76000

Local Institution, Querétaro

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY